Insider Trading Alert - SYMC, ICCC And G Traded By Insiders

Yesterday, Aug. 31, 2015, 70 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $889.92 to $16,133,353.20.

Highlighted Stocks Traded by Insiders:

Symantec (SYMC) - FREE Research Report

Shirk Brett, who is EVP, Veritas Worldwide Sales at Symantec, sold 68 shares at $21.29 on Aug. 31, 2015. Following this transaction, the EVP, Veritas Worldwide Sales owned 163,352 shares meaning that the stake was reduced by 0.04% with the 68-share transaction.

The shares most recently traded at $20.12, down $1.17, or 5.82% since the insider transaction. Historical insider transactions for Symantec go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 14,197
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 14,197
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 14,197

The average volume for Symantec has been 4.5 million shares per day over the past 30 days. Symantec has a market cap of $14.3 billion and is part of the technology sector and computer software & services industry. Shares are down 20.13% year-to-date as of the close of trading on Monday.

Symantec Corporation, together with its subsidiaries, provides security, backup, and availability solutions worldwide. Its products and services protect people and information in various environments from the mobile device and enterprise data center and to cloud-based systems. The stock currently has a dividend yield of 2.88%. The company has a P/E ratio of 12.2. Currently, there are 2 analysts who rate Symantec a buy, 3 analysts rate it a sell, and 15 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYMC - FREE

TheStreet Quant Ratings rates Symantec as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Symantec Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ImmuCell (ICCC) - FREE Research Report

Rothschild Jonathan E, who is Director at ImmuCell, bought 6,100 shares at $7.37 on Aug. 31, 2015. Following this transaction, the Director owned 521,636 shares meaning that the stake was boosted by 1.18% with the 6,100-share transaction.

The shares most recently traded at $6.72, down $0.65, or 9.7% since the insider transaction. Historical insider transactions for ImmuCell go as follows:

  • 4-Week # shares bought: 2,100
  • 12-Week # shares bought: 2,100
  • 24-Week # shares bought: 2,100

The average volume for ImmuCell has been 17,100 shares per day over the past 30 days. ImmuCell has a market cap of $22.0 million and is part of the health care sector and drugs industry. Shares are up 49.38% year-to-date as of the close of trading on Monday.

ImmuCell Corporation develops, acquires, manufactures, and sells products that enhance animal health and productivity in the dairy and beef industries in the United States and internationally. The company has a P/E ratio of 32.8.

Exclusive Offer: Get the latest Stock Analysis on ICCC - FREE

TheStreet Quant Ratings rates ImmuCell as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full ImmuCell Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Genpact (G) - FREE Research Report

Mehta Piyush, who is Senior Vice President at Genpact, sold 5,937 shares at $22.96 on Aug. 31, 2015. Following this transaction, the Senior Vice President owned 92,175 shares meaning that the stake was reduced by 6.05% with the 5,937-share transaction.

The shares most recently traded at $22.66, down $0.30, or 1.31% since the insider transaction. Historical insider transactions for Genpact go as follows:

  • 4-Week # shares bought: 23,500
  • 4-Week # shares sold: 13,850
  • 12-Week # shares bought: 23,500
  • 12-Week # shares sold: 13,850
  • 24-Week # shares bought: 23,500
  • 24-Week # shares sold: 13,850

The average volume for Genpact has been 657,500 shares per day over the past 30 days. Genpact has a market cap of $5.0 billion and is part of the services sector and diversified services industry. Shares are up 21.5% year-to-date as of the close of trading on Monday.

Genpact Limited provides business process outsourcing and information technology services worldwide. The company has a P/E ratio of 29.3. Currently, there are 5 analysts who rate Genpact a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on G - FREE

TheStreet Quant Ratings rates Genpact as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and increase in net income. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Genpact Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Dow Ends Off 125 Points as Caterpillar, 3M Earnings Disappoint

Dow Ends Off 125 Points as Caterpillar, 3M Earnings Disappoint

Multiple Tailwinds Take Shape That Could Drive BP Gains

Multiple Tailwinds Take Shape That Could Drive BP Gains

Tesla Critic Citron Research Changes Its Mind, Goes Long on the EV Maker

Tesla Critic Citron Research Changes Its Mind, Goes Long on the EV Maker

Verizon Beats Q3 Earnings Estimate, Postpaid Phone Additions Top Forecasts

Verizon Beats Q3 Earnings Estimate, Postpaid Phone Additions Top Forecasts

Philip Morris Rolls Out New Smokeless Cigs to Fire Up Sales

Philip Morris Rolls Out New Smokeless Cigs to Fire Up Sales